Last reviewed · How we verify
Intradermal injection of Mycobacterium w
Intradermal injection of Mycobacterium w is a Immunostimulant; mycobacterial vaccine Biologic drug developed by Ministry of Science and Technology, India. It is currently in Phase 3 development for Adjunctive immunotherapy in cancer (investigational), Tuberculosis and mycobacterial infections (investigational). Also known as: Immuvac.
Intradermal injection of Mycobacterium w stimulates innate and adaptive immune responses to enhance anti-tumor or anti-infectious immunity.
Intradermal injection of Mycobacterium w stimulates innate and adaptive immune responses to enhance anti-tumor or anti-infectious immunity. Used for Adjunctive immunotherapy in cancer (investigational), Tuberculosis and mycobacterial infections (investigational).
At a glance
| Generic name | Intradermal injection of Mycobacterium w |
|---|---|
| Also known as | Immuvac |
| Sponsor | Ministry of Science and Technology, India |
| Drug class | Immunostimulant; mycobacterial vaccine |
| Modality | Biologic |
| Therapeutic area | Immunology; Oncology |
| Phase | Phase 3 |
Mechanism of action
Mycobacterium w is a non-pathogenic mycobacterial strain that acts as an immunostimulant, activating dendritic cells and T-cell mediated immunity through pattern recognition receptors. This immune activation is intended to enhance the body's natural defense mechanisms against cancer or infectious diseases. The intradermal route of administration promotes local and systemic immune priming.
Approved indications
- Adjunctive immunotherapy in cancer (investigational)
- Tuberculosis and mycobacterial infections (investigational)
Common side effects
- Local injection site reaction (erythema, induration)
- Fever
- Fatigue
- Lymphadenopathy
Key clinical trials
- A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients (NA)
- Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19 (PHASE3)
- Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill (PHASE3)
- Efficacy and Safety Study of Immunomodulator as an Adjunct Therapy in Pulmonary Tuberculosis (TB) Retreatment Patients (PHASE3)
- Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients. (PHASE3)
- Safety Study of CADI-05 in Patients With Advanced Stage Melanoma (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intradermal injection of Mycobacterium w CI brief — competitive landscape report
- Intradermal injection of Mycobacterium w updates RSS · CI watch RSS
- Ministry of Science and Technology, India portfolio CI
Frequently asked questions about Intradermal injection of Mycobacterium w
What is Intradermal injection of Mycobacterium w?
How does Intradermal injection of Mycobacterium w work?
What is Intradermal injection of Mycobacterium w used for?
Who makes Intradermal injection of Mycobacterium w?
Is Intradermal injection of Mycobacterium w also known as anything else?
What drug class is Intradermal injection of Mycobacterium w in?
What development phase is Intradermal injection of Mycobacterium w in?
What are the side effects of Intradermal injection of Mycobacterium w?
Related
- Drug class: All Immunostimulant; mycobacterial vaccine drugs
- Manufacturer: Ministry of Science and Technology, India — full pipeline
- Therapeutic area: All drugs in Immunology; Oncology
- Indication: Drugs for Adjunctive immunotherapy in cancer (investigational)
- Indication: Drugs for Tuberculosis and mycobacterial infections (investigational)
- Also known as: Immuvac
- Compare: Intradermal injection of Mycobacterium w vs similar drugs
- Pricing: Intradermal injection of Mycobacterium w cost, discount & access